leisure time -WSS

leisure time

author：fashion 2025-09-30 12:08:16 - browse：746

Illustration of two DNA strands made of banknotes. -- health coverage from STAT — Adobe

The staff of the Institute for Clinical and Economic Review, or ICER, are known as the nerds of the drug industry: bespectacled killjoys who emerge a few times a year to scold drugmakers for pricing their latest cancer or MS advance far beyond reason.

But last year, they sat down and concluded a forthcoming treatment was worth up to $3.9 million — more than any medicine in history, more than a 45-year supply of Humira, the autoimmune drug often held up as an emblem of America’s runaway drug spending.

It was a testament to the power of a new class of gene therapies to deliver something pharma so rarely does: Genuine cures. The treatment, approved last week as Lenmeldy, may allow some babies born with an ultra-rare neurodegenerative disease called metachromatic leukodystrophy, or MLD, to grow up and live essentially normal lives.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Humana CEO Bruce Broussard to step down in 2024

Wikipedia

WSS

European regulators consider appeal over Amylyx ALS drug

Change Healthcare payments predicted restored March 15

With psoriasis trial ahead, Alumis raises $259 million

European regulators consider appeal over Amylyx ALS drug

STAT Readout Newsletter: Today in biotech, life science news

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

hotspot

leisure time

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Wellcome Trust names Røttingen as its new CEO

The high cost of giving birth even with insurance

Researchers CRISPR chickens in bid to protect them from bird flu

Alkermes shareholders re

IVF, abortion rights issues kick off Biden’s State of the Union

Guidelines to prevent youth baseball injuries need more muscle

European regulators recommend Amylyx's ALS drug be rejected

Wildfire smoke exposes gaps in outdoor worker protections

What the Wegovy shortage looks like for doctors — and for patients

leisure time

Just how do doctors, lawmakers, and the public define abortion?

Precocious puberty in girls comes with mental health risks

Bernie Sanders bashes nonprofit hospitals over their tax breaks

UnitedHealth quietly bought dozens of outpatient centers

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

With psoriasis trial ahead, Alumis raises $259 million

hotspot

Wikipedia

entertainment

hotspot